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A B S T R A C T
The aim of the study was to determine the effects of exercise training on improving the thoracic perivascular
adipose tissue (tPVAT) phenotype (inflammation, oxidative stress, and proteasome function) in metabolic syn-
drome and its subsequent actions on aortic function.
Methods: Lean and obese (model of metabolic syndrome) Zucker rats (n=8/group) underwent 8-weeks of
control conditions or treadmill exercise (70% of max speed, 1 h/day, 5 days/week). At the end of the inter-
vention, the tPVAT was removed and conditioned media was made. The cleaned aorta was attached to a force
transducer to assess endothelium-dependent and independent dilation in the presence or absence of tPVAT-
conditioned media. tPVAT gene expression, inflammatory /oxidative phenotype, and proteasome function were
assessed.
Results: The main findings were that Ex induced: (1) a beige-like, anti-inflammatory tPVAT phenotype; (2) a
greater abundance of •NO in tPVAT; (3) a reduction in tPVAT oxidant production; and (4) an improved tPVAT
proteasome function. Regarding aortic function, endothelium-dependent dilation was greater in exercised lean
and obese groups vs. controls (p < 0.05). Lean control tPVAT improved aortic relaxation, whereas obese control
tPVAT decreased aortic relaxation. In contrast, the obese Ex-tPVAT increased aortic dilation, whereas the lean
Ex-tPVAT did not affect aortic dilation.
Conclusion: Overall, exercise had the most dramatic impact on the obese tPVAT reflecting a change towards an
environment with less oxidant load, less inflammation and improved proteasome function. Such beneficial
changes to the tPVAT micro-environment with exercise likely played a significant role in mediating the im-
provement in aortic function in metabolic syndrome following 8 weeks of exercise.
1. Introduction
Metabolic syndrome (MetS) is a cluster of metabolic risk factors
(abdominal obesity, elevated blood pressure, impaired glucose toler-
ance, and dyslipidemia) that is prevalent in approximately 34% of
Americans [1]. Individuals with MetS have a three-fold greater risk of
death from cardiovascular disease (CVD) compared to healthy in-
dividuals [1,2]. As such, unravelling the mechanisms by which MetS is
associated with CVD mortality is of critical importance.
Aortic dysfunction is an important mechanism contributing to the
elevated incidence of CVD in MetS [3]. We and others have shown that
the perivascular adipose tissue surrounding the thoracic aorta (tPVAT)
can mediate its function [4,5]. Specifically, in lean rats, the presence of
tPVAT improved aortic dilation, whereas in obese rats (Zucker rat;
OZR) tPVAT induced vasoconstriction via a tumor necrosis factor alpha
(TNFα)-NADPH oxidase (NOX) 2 pathway [4]. We have also shown that
the proteasome function of tPVAT plays an important role with the
tPVAT mediated aortic dysfunction with obesity [4]. Indeed, an altered
redox status of cells can influence proteasome function [6] and, in a
vicious cycle, proteasome dysfunction could contribute to the existing
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oxidative and inflammatory environment within the tPVAT [7–9].
It is well established that aerobic exercise training (Ex) is associated
with improved cardiovascular health and reduced CVD morbidity/
mortality [10–12]. Ex is known to exert its beneficial effects by im-
proving the inflammatory and oxidative environment within the tissue
and systemically [13,14]. For example, Ex enhances nitric oxide (•NO)
bioavailability resulting in vascular homeostasis by modulating vas-
cular tone and decreasing advantageous platelet aggregation [15–18].
Our clinical work has demonstrated that 8-weeks of Ex improves ar-
terial health in patients with MetS [19]. However, the effects of Ex on
tPVAT and its subsequent actions on aortic function in MetS is unclear.
Further, although Ex has been shown to improve proteasome function
in muscle [20] the effect of Ex on proteasome function in tPVAT had not
been previously explored. As such, we examined the effects of Ex on
tPVAT function and its subsequent regulation of aortic reactivity with
MetS. We hypothesized that Ex would prevent tPVAT dysfunction by
improving proteasome function and reducing the oxidative and in-
flammatory environment of the tPVAT; thus, restoring •NO levels. We
subsequently hypothesized that such changes would diminish tPVAT-
induced impairment of aortic dilation in the context of MetS.
2. Methods
2.1. Animals
Male lean (LZR, n=16) and obese (OZR, a valid model of MetS,
n=16) rats were purchased from Envigo Laboratories at 7-9 weeks of
age and housed at the West Virginia University Health Science Center
(WVUHSC) animal care facility on an approved protocol by the
WVUHSC Animal Care and USE Committee (protocol# 1603000971).
Animals received standard chow and tap water ad libitum. At 16-17
weeks of age, animals were weighed then deeply anesthetized by in-
jection (i.p.) of sodium pentobarbital (50mg/kg). All rats received
carotid artery and jugular vein cannulation to measure mean blood
pressure and to administer heparin, respectively. Animals were then
euthanized via severing of the diaphragm and subsequent removal of
the aorta, which was placed in ice cold Krebs Henseleit Buffer (1.18mM
KH2PO4, 1.2 mM MgSO4•7H2O, 4.7 mM KCl, 25mM NaHCO3, 118mM
NaCl, 5.5 mM glucose, 26 μM Ethylenediaminetetraacetic acid (EDTA),
2.5 mM CaCl2•2H2O, bubbled with 95% O2). tPVAT was then carefully
removed from the aorta under a dissecting microscope, and the aorta
was sectioned into 3mm rings. Aliquots of the tPVAT were collected to
assess gene expression, inflammatory mediators, and to create condi-
tioned media to give its role on aortic function.
2.2. Exercise training protocol
The rats were randomly assigned into control (LZR-Con and OZR-
Con, n=8/group) or Ex (LZR-Ex and OZR-Ex, n=8/group) groups. The
Ex rats underwent 8 weeks of treadmill running on motor driven
treadmill for 5 days/week at 60-70% max speed at 5% grade. During
the first week, animals were acclimatized to the treadmill by running
for 20min, then the duration of the running was gradually increased by
10min/day until 60 min/day was achieved and sustained. A maximum
speed test was performed on each animal, and a target running speed
was set for 60-70% of that maximum. After acclimatization, the first
15 min of the total 60min consisted of a gradual increase until target-
running speed was reached. Mild electrical stimulus (≤0.3 mA) was
used at the rear of the treadmill to discourage rats from stopping. At the
end of the 8-week intervention there was a 48-hr wash-out period prior
to the terminal surgery.
2.3. Gene expression
As we previously described in detail [4], to assess gene expression,
50 mg sections of tPVAT were incubated at 37°C in physiological HEPES
buffer (43.7 mM NaCl, 80mM KCl, 1.17mM MgSO4•7H2O, 1.6 mM
NaH2PO4, 18mM NaHCO3, 0.03mM EDTA, 5.5 mM glucose, 5 mM
HEPES). After 1-hr tPVAT was removed and snap frozen in liquid N2. To
assess gene expression, tPVAT was homogenized in QIAzol and pro-
cessed for qPCR using the RNeasy Lipid Tissue MiniKit (Qiagen),
QuantiTect reverse transcription kit (Qiagen 205313). Equal con-
centrations of cDNA were then loaded into the QIAgility (Qiagen),
which mixed 20 μL PCR reactions with QuantiTect primer assays and
QuantiFast PCR master mix (Qiagen 204056). Relative quantification
was carried out by the 2∧(-ddCt) method as described previously [4].
The following primers were examined: uncoupling protein 1
(QT00183967), CD4 (QT00181811), CD68 (QT00372204), CD8a
(QT00177261), Gp91phox (QT00195300), p47phox (QT00189728),
nuclear factor-like 2 (QT00183617), superoxide dismutase -1
(QT00174888) and 2 (QT00185444), glutathione-disulfide reductase
(QT01083285), and β-actin was the control gene (QT00193473).
2.4. Measurement of oxidative stress
As we previously described in detail [4], dihydroethidium (DHE,
Invitrogen D1168) assays were performed on unfixed aortic rings as
well as tPVAT sections placed in individual wells of a 96 well plate
containing HEPES buffer. Samples were then set in OCT (Fisher
Healthcaretm), frozen, and then 8 μm sections were mounted on charged
slides and imaged with an EVOS fluorescent microscope (Invitrogen
EVOS FL Auto Cell Imaging System, Carlsbad, CA RFP light cube
ex:531/40em:593/40). Images were taken from 3 randomly selected
regions of each sample at 40X magnification. To control for image
quality, regions were excluded and new regions selected if the entire
sample was not in the same focal plane. Images were analyzed in Im-
ageJ by splitting the color channels generating a grey scale image for
the blue, red, and green channels. The red channel image was analyzed
for the raw intensity density and the blue channel used to count the
number of nuclei in the image. The intensity was divided by the number
of nuclei for each image, the 3 images from a sample were averaged
then the average of the 3 images were averaged to generate the mean
for each animal and represented as mean fluorescent intensity/nuclei.
DHE reacts with superoxide (O2•-) to produce a specific product, 2-hy-
droxyethidium (2-OH-E+), however, we are aware that other DHE-de-
rived products (e.g., E-E dimers and E-HE heterodimers) may contribute
to the measured fluorescence as previously reported [21]. To control for
O2•-_dependent signal, values were normalized to signal generated in
the presence of TEMPOL (i.e., fluorescent signal without tempol/
fluorescent signal with tempol). The mean of the LZR control animals
was used to calculate relative fold change.
To support results obtained with DHE and further assess oxidative
stress via measurement of H2O2 abundance, tPVAT and treated aortic
lysates were analyzed by coumarin boronic acid (CBA, Cayman
#14051) assay. CBA probe preparation and protocol were modified
from Zielonka et al. [22]. To assess the impact of tPVAT on aortic
oxidative stress, donor aortic rings were exposed to tPVAT for 1hr and
then aortic segments along with separate tPVAT sample lysates were
prepared by 5 rounds of freeze-thaw and passage through a 30-gauge
needle. In total, 10 μg of lysates were loaded, in triplicate, into wells of
a 384 well black sided clear bottom plate. Subsequently, assay buffer
composed of HBSS supplemented with 25mM HEPES, 1% BSA, 10uM
DTPA, 100uM L-NAME, 1mM Taurine, (L-NAME and Taurine were
added to inhibit/sequester peroxynitrite and hypochlorous acid re-
spectively, which could react with the probe) was added and then CBA
was added to each well at a final concentration of 0.5mM. One well
from each biological sample received an additional 1 KU/ml bovine
liver catalase to act as a negative control. Upon addition of the CBA,
plates were placed in a Biotek plate reader preheated to 37°C and read
kinetically (every minute for 3 h s) at excitation 350 nm and emission
450 nm. The average rate of fluorescence was determined over the
linear portion of the response and then normalized by subtracting out
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the rate of fluorescence from the negative control.
2.5. Nitric oxide measurement
As we previously described [4], aortic rings were placed in a 96 well
plate containing HEPES buffer and 4-amino-5methylamino-2′,7′-di-
fluorofluorescein diacetate (DAF-FM-DA, Invitrogen) supplemented
with L-Arginine (100 μM, MP biomedical Inc. 100736), and then sti-
mulated with acetyl-β-methylcholine chloride (methacholine (MCh),
1x10-6 M, Sigma-Aldrich A2251). The conditioned solution was read in
a plate reader excitation/emission at λ=495/515 nm. Fluorescence
was normalized to aortic length while L-NAME treatment was used for
validation.
2.6. tPVAT cytokine profile
tPVAT, at a ratio of 200mg/1mL, was incubated for 2h in HEPES
buffer to make conditioned media and examined for inflammatory
markers (Mesoscale discovery, V-plex K15059D-2) and high molecular
weight adiponectin (Mybiosource MBS020496). Additionally, tPVAT
homogenates were prepared and examined for inflammatory markers
(Mesoscale discovery, K15179C-9), 20S proteasome (Mybiosource
MBS730715), and Ubiquitin (Mybiosource MBS039103). All ELISA's
were run per manufacturer's instructions as described previously [4].
Additionally, samples were run in standard western blot procedures to
analyze the 19S proteasome (Rpt6, ENZO, BML-PW9265-0100) nor-
malized to β-actin (cell signaling #49705).
2.7. tPVAT tissue function
As we previously described [4], tPVAT homogenates were used to
examine total (CuZn and MnSOD) superoxide dismutase (SOD) activity
(Sigma-Aldrich 19160-1 KT-F), and proteasome function assays: LLVY-
AMC (ENZO BML-P802-0005), nLPnLD-AMC (Bachem I-1850.0005),
and RLR-AMC (Boston Biochem S-290) run per manufacturer's in-
structions. Additionally, to directly test 19S mediated 26S proteasome
function, tPVAT homogenates were run in Ub4 (lin)-GFP-35 (0.08 μg/
reaction) degradation assays carried out in 50 μl reactions using 96-
half-well black plates (Corning) at 37°C. GFP fluorescence was mea-
sured every 60 s for 4 h (ex/em:485/528) on BioTek plate reader
(BioTek Synergy HT, Winooski, VT). The Ub4 (lin)-GFP-35 substrate,
generously supplied by Dr. David M. Smith, was generated as described
by Martinez-Fonts and Matouschek [23]. V-max for each assay was
determined from 30 points on the linear portion of the kinetic read and
normalized to V-max in the presence of the 20S inhibitor MG132 to
account for background.
2.8. Aortic reactivity
As we previously described [4], 3 mm thoracic aortic rings (cleaned
of surrounding tissue) were rinsed in physiological salt solution and
mounted in a myobath chamber between a fixed point and a force
transducer (World Precision Instruments) pre-stretched, and allowed to
equilibrate for 1-hr in Krebs Henseleit Buffer aerated with 95%O2 and
5%CO2 at 37°C. After equilibration, aortic baseline tension was ad-
justed to 1 g and vessel viability was checked with 50mM of KCl and
rings not generating a rapid response were excluded from the study. To
test endothelial dependent dilation (EDD), aortic rings were pre-con-
stricted with phenylephrine PE, 1x10-7 M Sigma-Aldrich P6126) and a
stable tension was reached and recorded followed by increasing doses
of MCh (1x10-9 M-1x10-5 M). Dilation was calculated as %relaxation for
each dose of MCh from the following equation:
⎜ ⎟= ⎛
⎝
−
−
⎞
⎠
×Z x
Z y
%relaxation 100,
where z= tension after PE 1X10-7M, x= tension following a given does
of MCh, and y= baseline tension.
Following the MCh curve, the system was washed again and allowed
to return to baseline. To test the effect of tPVAT on EDD, tPVAT exudate
was snap frozen and used in crossover experiments. Exudate was added
to the bath and rings incubated for 30min. To directly test the role of
proteasome function in lean tPVAT on tPVAT mediated aortic dilation;
we incubated the tPVAT with MG132, a potent cell-permeable protea-
some inhibitor. Following the incubation, relaxation curves was per-
formed as described above. Pilot studies demonstrated no difference in
EDD between exudate vs. tPVAT tissue incubation.
2.9. Statistics
We have previously shown that in LZR that tPVAT improved aortic
dilation by 5%, and that OZR tPVAT reduced aortic function by 10%
[4]. As such, we performed a power analysis using PASS software with a
repeated measures analysis. The analysis was powered off the interac-
tion term between tPVAT and Ex group to establish a 10 ± 5% (SD)
improvement in aortic dilation with tPVAT in the OZR Ex group, for an
effect of 1.66. Assuming 0.5 correlation between time points and alpha
set to 0.05, total of 4 rats per group was needed to detect the interaction
effect with 0.97 power. However, we doubled that sample size to ac-
count for potential experimental issues. All data are represented as
mean ± standard deviation. All experiments were run in duplicate and
the average of the reads used as the mean for each animal. Data analysis
and graphing were conducted using GraphPad Prism 6 software
(GraphPad Software, Inc.) and p≤ 0.05 was set for statistical sig-
nificance. Comparisons between groups were conducted using a one-
way ANOVA, and a repeated measure ANOVA for aortic reactivity with
Tukey post-hoc test used to determine differences between groups.
3. Results
Animal Characteristics: Rat phenotypic characteristics are presented
in Table 1. As expected, by study design, the OZR (controls and Ex)
demonstrated greater body mass, MAP, glucose levels, and lipid abun-
dance when compared to LZR (controls and Ex). Crucial to data analysis
and conclusions from our experimental data, no differences in body
mass and MAP were noted within the LZR and OZR groups, except for
triglycerides and total cholesterol, which were lower in OZR-Ex com-
pared to OZR control.
3.1. tPVAT regulation of aortic function
3.1.1. Analysis of aortic oxidant state
In aortic rings, no differences were found in global aortic SOD ac-
tivity between the LZR-Ex and OZR-Ex groups vs. their respective
controls (Fig. 1A). However, a lower SOD activity was noted in both
OZR-controls and Ex rats vs. LZR groups (p < 0.05). In contrast, aortic
O2•- production, which was higher in OZR vs. LZR-controls, was lower
in OZR-Ex vs. OZR-controls (p < 0.01, Fig.1B and Fig. S1). Incubation
of the OZR-control aorta with OZR-control tPVAT increased aortic O2•-
Table 1
Rat phenotype.
LZR OZR
Control Exercise Control Exercise
Body Mass (g) 436 ± 18 370 ± 11* 606 ± 10* 627 ± 19*
MAP (mmHg) 107 ± 2 114 ± 2 133 ± 5* 134 ± 6*
Glucose (mg/dl) 98 ± 6 101 ± 8 184 ± 12* 154 ± 12*
TG (mg/dl) 25 ± 3 31 ± 3 124 ± 8* 82 ± 15*#
Data represented as Mean ± SD. *p < 0.05 vs. LZR-Con; #p < 0.05 vs. OZR-
Con; MAP, mean arterial pressure; TG, triglyceride.
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production almost 20-fold (p < 0.001). Whereas, incubation of the
OZR-Ex aorta with OZR-Ex tPVAT reduced aortic oxidative load to
minimal levels compared to OZR-Ex aorta without tPVAT incubation
(p < 0.01, Fig.1B and Fig. S3). Aortic O2•- production did not differ
between LZR-control and LZR-Ex in the presence or absence of its
tPVAT (Fig.1B, Figs. S1 and S2). To verify the role of tPVAT in the
induction of aortic oxidative stress by assessing H2O2 abundance, aortic
lysates from healthy donors, following their exposure to tPVAT from
the intervention groups, were exposed to CBA. Rate of H2O2 production
was significantly increased in aortic lysates exposed to OZR tPVAT
compared to LZR tPVAT which was abolished in the aortic lysates ex-
posed to OZR-Ex tPVAT (Fig. 1C).
3.1.2. Aortic reactivity
Aortic EDD was greater (p < 0.05) in LZR-Ex and OZR-Ex groups
(without tPVAT) compared to controls (Fig. 1 E&F). This was likely due
to a higher aortic •NO production in the Ex groups, as reflected by a
greater DAF-FM signal in the LZR-Ex and OZR-Ex groups vs. their
controls (p < 0.05). In addition, the DAF-FM signal was further in-
creased in the presence of tPVAT from LZR-Ex and OZR-Ex groups
(Fig. 1D). Aortic EDD in the OZR-Ex groups was increased in the pre-
sence of their own tPVAT, whereas in the OZR control group, the
control OZR tPVAT mediated aortic constriction rather than dilation
(Fig. 1F). With the LZR-Ex aorta, LZR-Ex tPVAT did not affect EDD,
however, in the LZR control group, aortic EDD was further improved
with LZR control tPVAT (Fig. 1E).
3.1.3. tPVAT environment
Uncoupling protein-1 (UPC-1) expression was higher (p < 0.01,
Fig. 2A) in the LZR and OZR-Ex groups vs. their respective controls.
Further, the OZR-Ex tPVAT had a lower expression of immuno-attrac-
tant cytokines, and immune cell specific markers vs. the OZR-control
tPVAT (Fig. 2B). Additionally, the production of •NO was lower in OZR-
control tPVAT compared to LZR-control tPVAT, and higher in OZR-Ex
tPVAT vs. OZR-control tPVAT (p < 0.05, Fig. 2C).
3.1.4. Oxidative stress
No difference was noted in tPVAT O2•- or H2O2 production between
LZR-controls and LZR-Ex. However, the elevated O2•- and H2O2 pro-
duction from tPVAT in OZR-controls was not evident in OZR-Ex group
(Fig. 2 D&E). The lower oxidative signal in OZR-Ex tPVAT may partially
be explained by a higher total SOD activity (p < 0.05, Fig. 2F), and a
lower gene expression of GP91 (the catalytic subunit of NOX2)
(p < 0.05, Fig. 2G) in the tPVAT OZR-Ex vs. OZR-controls. However,
no differences in tPVAT gene expression was noted between the OZR-Ex
and OZR-control groups for the NOX2 regulatory subunit, p47phox.
Expression of other redox factors, SOD 1 and 2, Nrf2, and GSR were
higher in the OZR-Ex vs. OZR-control group (data not shown).
3.1.5. Proteasome function
As the oxidative load/redox status of cells is known to impact the
ubiquitin-proteasome-system, we next examined tPVAT proteasome
function. The LZR-Ex group had a greater activity of the chymotrypsin-
Fig. 1. Effect of Exercise on tPVAT Mediated Aortic Function. Aortic total superoxide dismutase (SOD) activity (A, n=3–5), oxidative load measured by dihy-
droethidium (B) and coumarin boronate (C) with and without tPVAT incubation (n=5–8). Aortic nitric oxide (•NO) production in the presence or absence of tPVAT
(D, n=8) was measured by 4-Amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM). Aortic relaxation to methacholine (MCh) in the presence or
absence of tPVAT conditioned media in LZR (E, n=8) and OZR (F, n=8). Data are represented as Mean ± SD. For panels A-D, *p < 0.05, **p < 0.01,
***p < 0.001 compared to LZR or between groups connected by a bar. For panels E & F, *p < 0.05, **p < 0.01, ***p < 0.001 compared to LZR or OZR control
without tPVAT, #p < 0.05 vs. LZR or OZR Ex without tPVAT.
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Fig. 2. tPVAT Environment. qRT-PCR was used to assess tPVAT relative gene expression of phenotype indicators and immune cell markers (A, n=3), while
immune-attracting cytokines (keratinocyte chemoattractant (KC)/human growth-regulated. oncogene (GRO), monocyte chemoattractant protein-1 (MCP-1), and
lipocalin 1 were measured in tPVAT conditioned media (B, n=5). tPVAT production of •NO measured by fluorescent DAF-FM (C, n=8), oxidative load measured by
dihydroethidium (D, n=5) and coumarin boronate (E, n=5), and relative SOD activity (F, n=4–6). Finally, gene expression of two subunits of the NOX2 enzyme
(Gp91phox, p47phox) (G, n=3). Data are represented as Mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 compared to LZR or between groups connected by a
bar. UCP-1, uncoupling protein-1; CD, cluster of differentiation; eNOS, endothelial nitric oxide synthase; Gch-1, GTP cyclohydrolase; SOD, superoxide dismutase;
NOX2, NADPH oxidase 2 catalytic subunit (GP91); p47phox, NADPH oxidase 2 intracellular regulatory subunit.
E. DeVallance, et al. Redox Biology 26 (2019) 101285
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like active site and trypsin-like active site (p < 0.05). Whereas, the
tPVAT from the OZR-Ex group had greater activity of the chymotrypsin-
like active site and peptidylglutamyl-peptide hydrolyzing active site
(Fig. 3A) compared to OZR-control (p < 0.05). Additionally, a greater
tPVAT expression of the 20S catalytic core was noted in the OZR-Ex
(p < 0.05) but not in the LZR-Ex group (Fig. 3B). The improved 20S
core activity was accompanied by a lower expression of ubiquitin in
both LZR-Ex and OZR-Ex vs. their respective controls (p < 0.05,
Fig. 3B).
Ubiquitin degradation is dependent upon the 19S regulatory cap of
the proteasome, therefore we assessed 19S-dependent degradation. The
19S dependent degradation rate of fluorescent ubiquitin was greater in
the LZR-Ex and OZR-Ex groups compared to their respective controls
(p < 0.05, Fig. 3C). To test a direct effect of proteasome function on
tPVAT mediated aortic relaxation, LZR tPVAT and OZR-Ex tPVAT were
pretreated with 100 μM of MG132. Inhibition of proteasome function in
LZR tPVAT and OZR-Ex tPVAT resulted in a tPVAT mediated blunting
of aortic EDD (Fig. 3 D&E). These data highlight the beneficial effects of
Ex on tPVAT phenotype and subsequent function and suggest improved
tPVAT proteasome function as mechanism of Ex adaptation.
3.1.6. tPVAT cytokine production
Both oxidative stress and ubiquitinated proteins can stimulate pro-
inflammatory cytokines production. In tPVAT, LZR-Ex had similar anti-
and pro-inflammatory cytokine profile compared to LZR-controls
(Fig. 4). However, a greater abundance of HMW adiponectin was noted
in the LZR-Ex tPVAT vs. LZR-control (p < 0.05, Fig. 4A). OZR-Ex
tPVAT had 30-120% greater (p < 0.05) levels of IL-4, IL-5, IL-10, IL-13
and HMW adiponectin compared to OZR-controls (Fig. 4A). Interest-
ingly, the tPVAT in the OZR-Ex group had a 75% and 25% less
(p < 0.05) TNFα and TSP-1 concentration compared to OZR controls,
respectively, with no differences in tPVAT release of IFN-γ or IL-1β
(Fig. 4B). These data suggest Ex prevented the increased release of
TNFα from tPVAT associated with MetS, and increased IL-10 and re-
stored HMW adiponectin.
3.1.7. tPVAT crossover experiments
With both tPVAT dependent and independent effects on aortic
function improved following Ex, we examined if the aortic EDD in the
OZR-Ex was protected from the detrimental effects of tPVAT from OZR
controls. Indeed, incubation of the OZR-Ex aorta with non-Ex OZR
tPVAT blunted the aortic EDD compared to OZR-Ex aorta without
tPVAT (p < 0.01, Fig. 5). Interestingly, incubation of the OZR-Ex aorta
with LZR-control tPVAT improved aortic EDD to relatively the same
extent as when OZR-Ex aorta was incubated with its own tPVAT
(Fig. 5).
4. Discussion
Here we provide novel data suggesting that Ex prevented tPVAT
dysfunction in MetS with a corresponding improvement in tPVAT-
mediated aortic function. Specifically, we have shown that 8-weeks of
Ex in OZR significantly improved tPVAT •NO bioavailability, reduced
oxidative stress levels, increased proteasome function, and reduced
Fig. 3. Exercise Enhancement of Proteasome Function. tPVAT samples were measure for proteasome protease activity at all three 20S active sites (A, n=6–8);
LLVY (chymotrypsin-like), RLR (trypsin-like) and nLPnLD (caspase-like site). tPVAT samples were analyzed for levels of ubiquitin and the 20S proteasome beta-
subunit (B, n=5). Ubiquitin-dependent 26S proteasome substrate degradation was measured in tPVAT samples by a linier ubiquitin chain-GFP substrate (C, n=6–8).
Aortic relaxation was assessed in LZR aortic rings incubated with LZR tPVAT pre-treated with the proteasome inhibitor MG132 (D, n=4). Effects of proteasome
inhibition in OZR Ex tPVAT on endothelial dependent dilation of healthy (donor) aortas (E, n=4). Data are represented as Mean ± SD. For panels A-C, *p < 0.05,
**p < 0.01, ***p < 0.001 compared to LZR or between groups connected by a bar. For panels D and E, **p < 0.01 compared to LZR control tPVAT or OZR Ex
tPVAT with MG132.
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inflammatory cytokine profile. Additionally, our data suggested that
the improved tPVAT phenotype was essential for the improved aortic
function following Ex.
4.1. Effect of exercise on tPVAT
4.1.1. tPVAT phenotype
White adipose tissue phenotypes are associated with increased
oxidative stress and inflammation [24–26], and a loss of the brown-like
phenotype marker (uncoupling protein-1) [26]. Concomitantly, dysre-
gulation of •NO and endothelial •NO synthase uncoupling are implicated
in adipose dysfunction [27] and a loss in the brown/beige phenotype
[28,29]. Our data suggested that Ex limited the shift in the tPVAT
phenotype associated with MetS, reflected by reduced oxidative load,
inflammation, and immune populations and a greater Gch1 expression
in the OZR-Ex tPVAT. The increased Gch1 expression is important given
that it provides instructions for generating GTP cyclohydrolase 1, which
is involved in the production of tetrahydrobiopterin. Importantly, tet-
rahydrobiopterin is an essential cofactor for •NO generation via en-
dothelial •NO synthase. Indeed, our data showed an increase tPVAT •NO
production with Ex. The retention of the brown adipose phenotype in
OZR-Ex, in turn, may support a more reductive/anti-oxidant micro-
environment in tPVAT [25].
The direct mechanisms driving the promotion of •NO in tPVAT with
Ex is unknown. However, it has been suggested the myokines from the
Fig. 4. tPVAT Cytokine Profile. tPVAT conditioned media was assessed by multi-plex array for anti-inflammatory (A, n=5), and pro- inflammatory cytokine levels
(B, n=5). Data are represented as Mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 compared to LZR or between groups connected by a bar. IL, interleukin;
HMW adiponectin, high molecular weight adiponectin; TNFα, tumor necrosis factor alpha; IFN-γ, interferon gamma; TSP-1, thrombospondin 1.
Fig. 5. Exercise Does Not Protect the Aorta Against tPVAT Derived TNFα
Mediated Impairment. EDD of OZR-Ex aortas after incubation with either OZR
Ex-tPVAT (n=5) or with a crossover treatment with OZR control tPVAT (n=5),
or LZR control tPVAT (n=5). Data are represented as Mean ± SD. *p < 0.05,
***p < 0.001 compared to OZR-Ex aorta.
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exercising muscle [28] and autocrine signaling of adiponectin, which
was greater in OZR-Ex, can promote adipose •NO signaling and
browning of adipose tissue [30]. Specifically, metabolic products (lac-
tate) along with myokines, irisin and meteorin-like 1 induce adipocyte
browning (see detailed review [31]), which could have contributed to
the findings in the current study. However, a role for these factors in
restoring a healthy tPVAT phenotype or proteasome function in obesity
have not been established and warrants future investigation. Alter-
natively, sympathetic nervous system input has been implicated in the
brown adipose phenotype and Ex is known to increase sympathetic
innervation in both brown [32] and subcutaneous white adipose tissue
[33]. Thus, it is possible that similar mechanisms contributed to the
browning of the tPVAT in the OZR-Ex group. Detailed mechanistic
studies utilizing genetic manipulations are needed to determine the
essential factors mediating tPVAT •NO, proteasome function, and the
brown-like phenotype following Ex training.
Our previous work demonstrated the NOX2 enzyme was a major
source of oxidant production in OZR tPVAT [4]. In the present study, Ex
mitigated the expression of NOX2, which was accompanied by a sig-
nificant reduction in oxidative stress measured by DHE and CBA in the
OZR-Ex group. It is likely that alterations in immune cell number [34]
and function [35,36] along with increased SOD activity contributed to
this response. This idea is partial supported by our data, which showed
reduced gene expression of pro-inflammatory immune cell markers.
4.1.2. Proteasome Function
The greater oxidative load in OZR tPVAT may contribute to, and be
exacerbated by, proteasome dysfunction. It has been suggested that
more robust oxidative environments may cause the 19S cap to dis-
sociate from the 20S core reducing the ability to recognize and degrade
ubiquitinated proteins [6]. Proteasome dysfunction would be expected
to mediate a buildup of ubiquitinated proteins, which has been linked
to increased inflammatory cytokines, oxidants, and adipose dysfunc-
tion, all key pathologies in MetS [7–9]. Ex has been shown to improve
proteasome function in muscle [20] but the effect of Ex on proteasome
function in tPVAT had not been previously explored. We showed that
Ex improved both 20S and 26S proteasome activity, and the con-
comitant reduction in ubiquitin was also observed. The increased ac-
tivity of the 26S proteasome was likely via the upregulation of 19S cap
subunits, as the 19S regulatory particle is required for recognition of
ubiquitinated proteins (Fig. 3) [37] and 20S gate opening [38], which
facilitates protein degradation. Taken together, Ex resulted in a higher
concentration of the 19S regulatory cap (both in LZR and OZR) and the
20S core (OZR), which comprise the 26S proteasome. The greater
proteasome function likely improved the recognition and breakdown of
ubiquitinated proteins, supported by the Ub4 (lin)-GFP-35 substrate
assay results (Fig. 3), and the reduction in the inflammatory signaling in
MetS. The importance of proteasome function in the tPVAT was further
supported by our data showing inhibition of the proteasome (with
MG132) in LZR tPVAT and OZR-Ex tPVAT blunted the actions of tPVAT
on aortic EDD.
4.1.2. tPVAT Immune cells and Cytokines
In addition to adipocytes, PVAT also includes a stroma vascular
fraction, which is a heterogeneous population of cells including im-
mune cells (macrophages, B-and T-lymphocytes) [39]. Immune cells
that infiltrate dysfunctional adipose tissue are thought to be key drivers
of adipose tissue inflammation. Indeed, with obesity, the adipose tissue
inflammation is accompanied by increased infiltration [40] and phe-
notypic switching [41] of macrophages to a proinflammatory activation
profile. The proinflammatory macrophage phenotype (known as M1)
produce inflammatory cytokines such as TNFα and IL-6. In addition,
evidence suggests that T cells also play an essential role in the devel-
opment of adipose tissue inflammation [42,43]. CD8+ T cells produce
monocyte chemoattractant proteins (MCPs) and macrophage in-
flammatory proteins, which modulate the infiltration of macrophages in
adipose tissue [44]. Further, cytotoxic CD8+ T cells secrete TNFα, IL-2,
IFN-γ, whereas treatment of obese mice with CD8-specific antibodies
was shown to attenuate M1 macrophage infiltration and adipose tissue
inflammation [45]. Our data also showed that in the OZR tPVAT, the
mRNA expression of these pro-inflammatory markers were elevated
compared to lean controls. In contrast, the OZR-Ex group showed a
reduced expression of these inflammatory cell markers (CD68, and
CD8) compared to OZR control, which corresponded with a lower
concentration of TNFα, IFN-γ, IL-6, and IL-1β. These data suggest that
Ex reduced tPVAT inflammation, in part, by preventing the infiltration
of T-cells and macrophages. Previous studies have reported that even a
single exercise bout, albeit in epididymal fat (white adipose tissue), can
induce a phenotypic switch in macrophage populations (i.e., from M1
to M2), and reduce TNFα, IL-1β and MCP-1 mRNA levels [36]. Simi-
larly, Ex for 16 weeks in mice feed a high fat diet, reduced
CD11c + inflammatory macrophages and CD8+ T cells in epididymal
adipose tissue, which was accompanied by a lower mRNA expression of
TNFα compared to the obese mice without Ex [46]. These anti-in-
flammatory Ex adaptations likely played an important role in preser-
ving/restoring the beneficial relationship between tPVAT and aortic
function.
The OZR-Ex group had two lower inflammatory cytokine signaling
pathways compared to OZR-Con. First, ubiquitin products [7,8], and
second oxidative load [47]. tPVAT from OZR-Ex had a lower production
of TNFα, and higher production of IL-10 and HMW adiponectin vs.
OZR-controls. IL-10 is a known inhibitor of TNFα [48] and O2•- [49].
The reduced production of TNFα and immune cells in OZR-Ex tPVAT
likely had 3 important actions on the autocrine signaling of tPVAT.
First, lower TNFα levels removes autocrine activation of oxidative
stress from tPVAT, which can subsequently: a) decrease the oxidative
dissociation of the 19S from the proteasome thereby imp roving pro-
teasome function; b) decrease the sequestration of •NO; and c) decrease
inflammation-controlled gene expression. Second, flipping the TNFα-
adiponectin balance towards adiponectin would promote the autocrine
activation of enhanced •NO abundance and phenotype maintenance
[50]. Third, lower TNFα levels could downregulate TSP-1 (Fig. 3). In-
deed, increased TSP-1 can inhibit •NO production [51], mediate im-
mune cell infiltration [52], and negatively regulate microvascular
density [42,53] all of which may negatively impact tPVAT phenotype
and function. These actions would have important implications on the
tPVAT mediated function of the aorta [50,54].
4.2. Role of tPVAT on aortic function
4.2.1. Aortic function
It is well known that Ex can improve arterial health, in particular,
the hemodynamic forces (i.e., shear stress) exerted during exercise on
the arterial wall plays a key role in regulating arterial function and
structure [55]. This shear stress response, sensed by endothelial cells,
can affect multiple signaling pathways (integrins, ion channels, G-pro-
tein-coupled receptors, and receptor tyrosine kinases), which in turn
lead to the establishment of an adaptive response (see detailed reviews
for further information [56,57]). It is also plausible that the hemody-
namic forces exerted on the arterial wall and smooth muscle, which can
improve the oxidative (improved efficiency of the antioxidant system
and reduced superoxides) and inflammatory environment of the vas-
culature, could have exerted beneficial effects on tPVAT. Indeed, our
study data confirmed the classic vascular adaptation following Ex
where by aortic O2•- was less and •NO abundance greater in OZR-Ex,
respectively, which improved aortic EDD (independent of changes in
body weight or MAP). Surprisingly, we found no change in SOD activity
in either Ex group. However this may be due to differing effects of Ex on
the various isoforms of SOD [18], or due to the time in which the
sample was analyzed [58]. Despite the important of exercise induced
shear stress on improving arterial function, it has been shown that in
arteries with a similar structure and exposed to similar hemodynamic
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forces display distinct arterial phenotypes [59]. Such data would sug-
gest that other local factors besides shear stress influence the regulation
of arterial function, and that tPVAT may be involved [60].
4.2.2. tPVAT mediated aortic function
Although the mechanism(s) by which Ex improved tPVAT health,
and the subsequent actions on the aorta, are not fully known they may
be concomitantly mediated by autocrine, endocrine, and mechanical
signaling. In the current study, improved tPVAT mediated aortic EDD
was likely the result of increased •NO bioavailability and reduced ac-
tivation of aortic O2•- an/or H2O2 in OZR-Ex tPVAT. We have previously
shown that tPVAT-induced aortic O2•- was primarily mediated by TNFα
in OZR [4]. Thus, diminished TNFα release from OZR-Ex tPVAT is a
likely explanation for the reduction of tPVAT-induced aortic O2•- and
H2O2 observed in the OZR Ex group. Further, increased IL-10 levels
noted in the OZR-Ex tPVAT may have limited the activation of oxidative
enzymes in the aorta, specifically IL-10 can inhibit NOX-derived O2•-
[49], a significant contributor to aortic O2•- production [4,61]. The O2•-
scavenging of •NO is a well-known mediator of endothelial dysfunction,
suggesting the significant reduction in tPVAT-induced aortic O2•- pro-
duction, contributed to the higher levels of •NO found in OZR-Ex aorta.
In addition, to the Ex-induced changes in TNFα, the increased se-
cretion of HMW adiponectin identified in OZR-Ex tPVAT may have
contributed to the improved aortic EDD observed in the current study.
Adiponectin has previously been shown to enhance EDD responses to
acetylcholine in healthy blood vessels. This study by Du et. al. [62],
demonstrated that adiponectin signaling, through adiponectin receptor
1 on vascular endothelial cells, mediated eNOS phosphorylation and
production of •NO, in a caveolin-1 dependent manner. In the current
study, HMW adiponectin released from OZR-Ex tPVAT was detected at
a similar level to the concentration used in the Du et. al. [62], study to
induce eNOS phosphorylation (4 μg/ml vs. 5 μg/ml respectively). These
data suggest that the release of HMW adiponectin from Ex tPVAT
contributed to the enhanced EDD, via increased •NO production. Con-
versely, TSP-1 has been shown to inhibit the activation of eNOS and
reduce the production of •NO [63]. Indeed, we observed a reduction in
the levels of TSP-1 following Ex training in the OZR-Ex group, which
could have contributed to the increased levels of •NO. Taken all to-
gether, these data suggest tPVAT function and cytokine profile sig-
nificantly impacted aortic endothelial function and that Ex induced
improvements in tPVAT phenotype that correspondingly improved
aortic EDD.
Indeed, we have previously shown that a healthy (LZR) aorta was
not protected against the OZR tPVAT activation of aortic O2•-, in that
LZR aortic EDD was reduced by∼ 25% in the presence of OZR tPVAT,
with a corresponding reduction in •NO production [4]. Conversely,
exposing the unhealthy (OZR) aorta with LZR tPVAT lowered O2•- and
improved •NO production, and improved EDD in the OZR aorta
by∼ 20% [4]. Further support for this idea comes from our crossover
experiments in the current study, which demonstrated the OZR-Ex aorta
was not protected against the inflammatory and oxidative insult re-
leased from OZR-tPVAT, and proteasome inhibition of OZR-Ex tPVAT
impaired healthy donor aortic EDD. Interestingly, crossover experi-
ments exposing OZR-Ex aorta to LZR-control tPVAT improved EDD to a
similar extent as OZR-Ex aorta exposed to its own tPVAT. Furthermore,
these data suggest that the tPVAT plays an important role in modulating
aortic function in obesity, and following Ex, the improved aortic
function was, in part, dependent on reduction of inflammatory cytokine
release and proteasome function improvement in tPVAT (highlighted in
Figs. 3 and 4). On a cautionary note, it was recently shown that Ex can
result in very distinct adipose tissue depot-specific adaptations, i.e., the
various adipose tissue depots responded quite differently to the Ex
stimulus [64]. Thus, future research should further explore how the
PVAT around the aorta is affected by Ex compared to other tissue de-
pots.
To date, only two other studies have examined the effect of Ex on
PVAT regulation of vascular function. In the previous studies, no effect
of Ex on tPVAT mediated EDD were found in healthy rats [65], or in a
rat model of diet induced obesity [66]. One potential reason for the
different results is that the current study incorporated a vertical work
component utilizing a 5% incline compared to 0%. In the diet induced
obesity study [66], obesity did not impair the tPVAT-aorta relaxation
relationship, therefore the effects of Ex in preventing or reversing dis-
ease mediated tPVAT dysfunction could not be evaluated and further
highlights the novelty in the present data.
4.2.3. Limitations
The current study is not without its limitations. One limitation re-
flects the introduction of Ex during the development of MetS. Thus,
these data should be interpreted as such, and future studies to de-
termine the therapeutic efficacy of Ex after the development of MetS on
tPVAT function and regulation of aortic EDD. However, we have pre-
viously shown that at 9 weeks of age the OZR already exhibits some
vascular impairment and alterations in circulating cytokines [67]. Thus,
our data may reflect a halt in the progression of MetS induced aortic
pathology, and a reversal in the impairments present at 9 weeks of age.
Additionally, small numbers were utilized in gene expression experi-
ments due to limited LZR tPVAT quantity. However, many genes
showed robust and consistent responses such as uncoupling protein-1
and TNF. In addition, only global SOD activity was measured and data
may not reflect regional alterations in specific isoforms. We recognize
the inherent flaws associated with DHE imaging, however, appropriate
controls measures were taken. Furthermore, we verified the elevated
ROS production of the tPVAT and treated aortic lysates by the CBA
assay and observed similar results. Another limitation to this study is
the use of an ex-vivo approach (wire myography) to examine the in-
teraction between tPVAT and aortic function. Although, wire myo-
graphy provides a well-controlled and detailed approach to understand
the physiological, pharmacological, and active biomechanical proper-
ties of blood vessels it does however have its limitations. Notably the
crosstalk between endothelium and blood flow and between adventitia
and adjacent tissue are disturbed under ex-vivo conditions. Further-
more, hormones, inflammatory and neural transmitters, and mechan-
ical interactions are difficult to mimic in an ex-vivo system. As such, the
ex-vivo measurements reflect the general function of the endothelium
and smooth muscle without the additional effects of the systemic cir-
culation. Future studies should examine how modulating tPVAT phe-
notype (via Ex, or diseases states) impacts aortic health and function in
an intact system (i.e., using non-invasive imaging techniques). Lastly,
for logistical reasons the current study only examined male rats. Sex
steroids play an essential role in the production and function of fat and
a recent study in a porcine model noted that the regulation of coronary
artery tone by PVAT differed by sex [68]. Whereby, PVAT from female
pigs produced an anti‐contractile, relaxation response, that was not
evident in PVAT from male pigs. We have previously shown that aortic
EDD was similar in lean male and female rats [69], however with
obesity the female OZR had a great aortic EDD than OZR male [70]. To
date, it is unknown if the interplay between the aorta and tPVAT differs
by sex. However, to affectively examine the potential role of sex-
mediated effects, one must examine the 3 stages of the estrous cycle due
to the drastic change in ovarian steroids. Future research is needed to
explore the role of sex on mediating tPVAT aortic function.
5. Conclusions and prospective
Fig. 6 provides a summary of the main findings. The present study is
the first examination of the Ex effect on tPVAT and its regulation of
aortic function in MetS. Ex prevented the increase in oxidant load and
inflammation associated with MetS, while enhancing •NO and protea-
some function in tPVAT. The improved tPVAT cytokine profile and
proteasome function following Ex promoted aortic •NO and EDD and
our data further suggested these changes were important in the aortic
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adaptations to Ex. This was supported by the impairment of OZR-Ex
aortic EDD treated with OZR tPVAT, and OZR-Ex tPVAT pretreated
with a proteasome inhibitor which impaired healthy donor aortic EDD.
Thus, we suggest that the tPVAT adaptation to Ex as a potential me-
chanism promoting cardiovascular benefits, and therapeutically tar-
geting tPVAT in combination with Ex or other vascular therapeutics
might accelerate beneficial vascular adaptation and reduce cardiovas-
cular burden.
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